Testosterone for renal insufficiency, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Feb 2022: Trial registered, NCT05249634
  2. 15 Mar 2022: Trial started, NCT05249634

The trials

NCT05249634: Testosterone Treatment in Men With Chronic Kidney Disease

State
Under way
Phase
Phase 2
People
20 planned
Started
15 Mar 2022
Primary completion
Jun 2028
Arms
treatment
Results
None posted
  1. 21 Feb 2022: Trial registered
  2. 15 Mar 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Androderm, Androgel, Android-t, Androlan, High dose testosterone, Intrinsa, Jatenzo Pill, Livensa, Natesto, Subcutaneous Testosterone Implants, Vogelxo, topical testosterone.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.